Biomanufacturing Automation Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 3.7 billion
Estimated Base Value
2035 Forecast
US$ 10.5 billion
Projected Market Value
CAGR 2026–2035
11.0%
Compound Annual Growth
Largest Segment
Automated Upstream Processing Systems
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
Asia Pacific
Fastest Growing Region
Asia Pacific
Top Country
United States
By Market Share
Largest market
Key Players
Sartorius
Emerging Players
Cellares, Ori Biotech
Biomanufacturing Automation Market Overview
The Biomanufacturing Automation Market within the pharmaceuticals sector involves the integration of automated systems, robotics, software, and advanced control technologies across biopharmaceutical production stages. This includes processes like cell culture, fermentation, purification, formulation, and fill-finish. The market aims to enhance efficiency, scalability, reproducibility, and regulatory compliance, minimizing human intervention and reducing operational costs. Key purchasers include pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, academic and research institutions, vaccine manufacturers, and gene and cell therapy manufacturers.
The Biomanufacturing Automation Market is estimated at $3.7 Bn in 2025 and is forecast to reach $10.5 Bn in 2035, growing at a CAGR of 11.0% (2025-2035). Demand is driven by the need to reduce operational costs, improve efficiency, and the rising global demand for biologics and advanced therapies. Strict regulatory requirements also encourage automation for quality and consistency. However, high upfront investment costs, complex regulatory validation processes, and the challenge of integrating new automation with legacy systems can restrain market expansion.
The market is segmented by Type (e.g., Automated Upstream Processing Systems, Robotics & Automated Material Handling), Technology (e.g., Artificial Intelligence & Machine Learning, Industrial Internet of Things & Sensors), Application (e.g., Upstream Bioprocessing, Quality Control & Testing), End-User (e.g., Pharmaceutical & Biopharmaceutical Companies, Gene & Cell Therapy Manufacturers), Component (e.g., Sensors & Transmitters, Robotic Arms & End-Effectors), and Deployment (e.g., On-Premise Deployment, Continuous Bioprocessing Automation). Geographically, it is served across Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Leading companies include Sartorius, Lonza, Revvity, Bio-Rad Laboratories, and Tecan. The full report provides a detailed analysis of these segments, market dynamics, and competitive landscape.
Market Definition & Overview
The Biomanufacturing Automation Market within the pharmaceuticals sector encompasses the adoption and integration of automated systems, robotics, software, and advanced control technologies across various stages of biopharmaceutical production. This market focuses on enhancing the efficiency, scalability, reproducibility, and regulatory compliance of processes such as cell culture, fermentation, purification, formulation, and fill-finish. It includes solutions designed to minimize human intervention, reduce operational costs, accelerate time-to-market for biologics, and ensure consistent product quality, thereby transforming traditional biofactory operations into streamlined, data-driven, and highly productive environments essential for modern drug development and manufacturing.
Scope
- Global coverage, focusing on major biopharmaceutical production hubs across North America, Europe, and Asia-Pacific.
- Market analysis spans the period from 2025 to 2035, including historical data and future forecasts.
- Covers automation solutions specifically applied within the pharmaceutical and biotechnology industries.
- Analyzes both upstream and downstream processing automation in biomanufacturing.
Inclusions
- Automated bioreactors and fermenters for cell culture and microbial fermentation.
- Robotic systems for sample handling, cell line development, and purification processes.
- Process Analytical Technology (PAT) and smart sensors integrated into bioprocesses.
- Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), and SCADA tailored for biomanufacturing.
- Automated liquid handling systems and dispensing technologies for biopharmaceutical applications.
- Integrated single-use technology solutions within automated bioprocessing workflows.
Exclusions
- Automation solutions for traditional chemical pharmaceutical manufacturing.
- Automation equipment primarily for academic research not directly related to biomanufacturing production.
- Manual laboratory equipment and instruments without significant automation features.
- General IT infrastructure or enterprise software not specifically designed for biomanufacturing automation.
- Automation technologies for non-pharmaceutical bioproducts like biofuels or industrial enzymes.
Market Size Forecast
Executive Summary
• The Biomanufacturing Automation market is valued at $3.7 Bn in 2025 and is forecast to reach $10.5 Bn by 2035, reflecting a robust CAGR of 11.0% as demand accelerates across every major segment and region over the ten-year outlook.
• Automated Upstream Processing Systems leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at XX.X%, while Emerging Areas is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intense competitive dynamics are driving strategic partnerships and acquisitions among established automation providers, aiming to offer integrated, end-to-end solutions that capture increasing demand for biofactory efficiency and agility.
• The surging pipeline of complex advanced therapies, particularly cell and gene therapies, acts as a primary growth catalyst, mandating highly flexible and scalable automation platforms for efficient, compliant manufacturing workflows.
• Significant technological advancements, including AI/ML integration and digital twin adoption, are transforming process optimization, predictive maintenance, and data-driven decision-making, setting new benchmarks for operational intelligence and product quality.
• While established biopharma hubs in North America and Europe drive initial adoption, the Asia-Pacific region is emerging as a critical growth frontier, propelled by significant investment in new bioprocessing capabilities and localized manufacturing needs.
• Strategic investments in automation are pivotal for bolstering biomanufacturing supply chain resilience, mitigating geopolitical risks, and accelerating time-to-market for novel biologics, emphasizing localized, agile production capabilities globally.
• The forward outlook points towards increasingly autonomous, digitally integrated biofactories, leveraging next-generation robotics and enhanced data security protocols to achieve unparalleled operational consistency and regulatory compliance across global networks.
Key Market Takeaways
Critical findings and data points from this market research study.
Market Value Baseline
The Biomanufacturing Automation Market stood at $3.7 billion in the base year, demonstrating its established presence.
Exceptional Growth Trajectory
Forecasted to achieve $10.5 billion by the forecast year, the market is set for exceptional growth with a CAGR of 11.0%.
Digitalization Trend
A key trend involves the integration of advanced digital technologies and data analytics to optimize biomanufacturing processes.
Upstream Dominance
Automation in upstream processing, encompassing cell culture and fermentation, is expected to remain a dominant segment.
Regional Leadership
North America is anticipated to maintain its leadership position, propelled by substantial investments in biotech and pharmaceutical R&D.
Efficiency Imperative
The imperative to enhance operational efficiency, reduce costs, and ensure product quality is a major catalyst for market expansion.
Market Dynamics
Market Trends
- AI and machine learning are increasingly adopted for process optimization.
- Shift towards modular and flexible automation solutions is evident.
- Growing demand for real-time monitoring and data analytics exists.
- Emphasis on digital twin technology for process simulation is rising.
Growth Drivers
- Need to reduce operational costs and improve biomanufacturing efficiency.
- Rising global demand for biologics and advanced therapies fuels growth.
- Strict regulatory requirements drive automation for quality and consistency.
- Shortage of skilled labor necessitates automated solutions in production.
Restraints
- High upfront investment costs hinder wider automation adoption.
- Complex regulatory validation processes delay market entry and implementation.
- Shortage of skilled workforce limits advanced system operation and maintenance.
- Integrating new automation with diverse legacy systems poses significant challenges.
Opportunities
- Developing advanced robotics for sterile biomanufacturing environments.
- Integrating IoT for comprehensive factory connectivity and data exchange.
- Expansion into emerging markets with growing biopharma industries is key.
- Customized automation solutions for personalized medicine production offer potential.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Automated Upstream Processing SystemsAutomated Downstream Processing SystemsLaboratory Automation WorkstationsProcess Control & Monitoring SystemsManufacturing Execution Systems & Data ManagementRobotics & Automated Material HandlingIntegrated Bioprocess Automation Platforms |
| By Technology | Artificial Intelligence & Machine LearningIndustrial Internet of Things & SensorsAdvanced Process Control & OptimizationDigital Twin & SimulationCloud & Edge ComputingCyber-Physical SystemsRobotics & Vision Systems |
| By Application | Upstream BioprocessingDownstream BioprocessingFill & Finish OperationsQuality Control & TestingProcess Development & OptimizationFormulation DevelopmentWarehouse & Logistics Automation |
| By End-User | Pharmaceutical & Biopharmaceutical CompaniesContract Development and Manufacturing OrganizationsAcademic & Research InstitutionsVaccine ManufacturersGene & Cell Therapy ManufacturersBiosimilar Manufacturers |
| By Component | Sensors & TransmittersActuators & Control ValvesProgrammable Logic Controllers & Distributed Control SystemsHuman-Machine InterfaceRobotic Arms & End-EffectorsPumps & Flow ControllersVision Systems & Barcode ReadersIndustrial Personal Computers & Workstations |
| By Deployment | On-Premise DeploymentCloud-Based DeploymentHybrid DeploymentModular & Scalable SystemsFixed & Dedicated SystemsContinuous Bioprocessing AutomationBatch Bioprocessing Automation |
Regional Analysis
- North America leads the biomanufacturing automation market due to its robust pharmaceutical and biotech industries. Extensive R&D investments, early adoption of advanced automation technologies, and a supportive regulatory framework drive market dominance, fostering innovation and efficiency in biofactory operations.
- The Asia-Pacific region is experiencing the fastest growth in biomanufacturing automation. This surge is driven by expanding healthcare investments, rising demand for affordable biologics, increasing government initiatives to bolster local production capabilities, and the proliferation of advanced manufacturing facilities.
- Europe exhibits a noteworthy trend towards integrating Industry 4.0 principles and sustainable practices within biomanufacturing automation. The region focuses on end-to-end digitalization and localized production chains, driven by strong EU initiatives, aiming for enhanced efficiency and supply chain resilience.
| Asia PacificXX.X% | North AmericaXX.X% | EuropeXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A mature yet highly innovative market, characterized by significant R&D spending, strong regulatory frameworks, and early adoption of advanced automation technologies in biopharmaceutical production.
- Focus on efficiency and reducing time-to-market for novel therapies.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Experiencing steady growth in biomanufacturing, primarily driven by increasing healthcare expenditure, expanding local production capabilities, and a rising demand for biologics.
- Adoption of automation is gradually increasing to enhance production efficiency and quality.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A well-established biopharmaceutical hub with a strong focus on advanced manufacturing processes, digital transformation, and sustainable production.
- The region benefits from robust academic research and industry collaboration driving automation innovation.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Asia Pacific represents a developing share of this market, with growth shaped by regional demand and investment trends.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A nascent but rapidly developing market, propelled by government visions for localized pharmaceutical production and diversification of economies.
- Investments in new biomanufacturing facilities are creating opportunities for automation technology implementation.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The U.S. leads in biopharmaceutical R&D and manufacturing, driving significant demand for advanced automation solutions to enhance efficiency, quality, and compliance in its vast biomanufacturing sector. Continuous innovation in biotechnology and personalized medicine further fuels the adoption of sophisticated automation technologies. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | As the largest pharmaceutical market in Latin America, Brazil is heavily investing in local biopharmaceutical production, particularly biosimilars and vaccines, which necessitates the implementation of modern automation systems for scaling up manufacturing and ensuring product quality. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Germany stands as a powerhouse in pharmaceutical manufacturing and engineering, with a strong focus on high-quality production and a robust ecosystem for biopharma innovation, making it a key adopter of advanced biomanufacturing automation. |
| 4 | China | US$ XX.X Mn | XX.X% | China is rapidly expanding its biopharmaceutical industry with massive government investment and a strong drive for domestic innovation and manufacturing, making it a leading market for advanced biomanufacturing automation to achieve high-volume and high-quality production. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | Driven by Vision 2030, Saudi Arabia is making substantial investments to localize pharmaceutical and biopharmaceutical manufacturing, creating a nascent but rapidly growing market for state-of-the-art automation systems in new biofactory developments. |
Countries Covered (28)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, Switzerland, France, Ireland, Italy, Spain, Russia, Rest of Europe, China, Japan, South Korea, India, Taiwan, Singapore, Malaysia, Australia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Sartorius | XX.X% | Drive bioprocessing innovation and digitalization to enhance manufacturing efficiency and flexibility for biopharmaceutical production. | — | — | BioreactorsFermentersChromatography Systems+1 |
| 2 | Lonza | XX.X% | Be the leading global partner for the biopharmaceutical industry, offering comprehensive contract development and manufacturing organization (CDMO) services across modalities. | — | — | CDMO ServicesCell & Gene Therapy ManufacturingBiologics Manufacturing+1 |
| 3 | Revvity | XX.X% | Empower customers to accelerate research and innovation in life sciences and diagnostics through a comprehensive portfolio of tools and services. | — | — | Imaging SystemsGenomics SolutionsLab Automation+1 |
| 4 | Bio-Rad Laboratories | XX.X% | Provide innovative products and solutions for life science research and clinical diagnostics through a broad range of technologies. | — | — | Electrophoresis SystemsPCR SystemsWestern Blotting Systems+1 |
| 5 | Tecan | XX.X% | Be a leading global provider of laboratory instruments and solutions for automated workflows in life science research and clinical diagnostics. | — | — | Liquid Handling SystemsMicroplate ReadersCell Imaging Systems+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Sartorius, Lonza, Revvity, Bio-Rad Laboratories, Tecan, Hamilton Company, Eppendorf, Mettler-Toledo, Repligen, Bio-Techne, GEA Group, Spirax-Sarco Engineering, Miltenyi Biotec, Getinge, Terumo Corporation, Shimadzu Corporation, Promega, Biotage, Infors HT, ESCO Global
The global Biomanufacturing Automation market features a competitive landscape led by Sartorius, Lonza, Revvity, Bio-Rad Laboratories, Tecan, and Hamilton Company, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Sartorius
Lonza
Revvity
Bio-Rad Laboratories
Tecan
Hamilton Company
Eppendorf
Mettler-Toledo
Repligen
Bio-Techne
GEA Group
Spirax-Sarco Engineering
Miltenyi Biotec
Getinge
Terumo Corporation
Shimadzu Corporation
Promega
Biotage
Infors HT
ESCO Global
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
New AI-Driven Bioprocess Software Promises Efficiency Boost
A leading biomanufacturing automation firm has unveiled an advanced AI-powered software platform aimed at optimizing upstream and downstream processes, predicting significant reductions in batch variation and operational costs for biologics production.
Global Pharma Giant Partners for Fully Automated Cell & Gene Therapy Facility
A major pharmaceutical company announced a strategic partnership with a top automation solutions provider to develop a state-of-the-art, fully automated manufacturing facility dedicated to next-generation cell and gene therapies.
Industrial Automation Leader Acquires Bioreactor Control Specialist
A prominent industrial automation conglomerate completed the acquisition of a specialized company known for its advanced bioreactor control systems and software, significantly expanding its portfolio within biofactory automation.
Robotics Startup for Bioproduction Secures Significant Series B Investment
A cutting-edge startup developing autonomous robotic systems for automated cell culture, media preparation, and sample handling in biomanufacturing successfully closed a substantial Series B funding round, accelerating its product development and market expansion.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $3.7 Bn |
| Market Size (Forecast) | $10.5 Bn |
| CAGR | 11.0% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 28 Countries |
| Segments Covered | 6 Segments, 42 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Biomanufacturing Automation Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
VP, Corporate Strategy
Industrial manufacturing company
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Director, Investment Research
Private equity firm
“We now use these reports in every planning cycle. The regional granularity, and the same numbers across the report, the dashboard and the Excel, save our team real time.”
Head of Market Intelligence
Specialty chemicals company
Frequently Asked Questions
Common questions about this report and our research
The Biomanufacturing Automation Market is estimated at $3.7 Bn in 2025. It is forecast to reach $10.5 Bn in 2035, indicating significant expansion within the pharmaceuticals sector.
The Biomanufacturing Automation Market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 11.0% between 2025 and 2035. This growth reflects increasing adoption of automated solutions.
The market is segmented by Type, Technology, Application, End-User, Component, and Deployment. These include areas like Automated Upstream Processing Systems, Artificial Intelligence & Machine Learning, Upstream Bioprocessing, Pharmaceutical & Biopharmaceutical Companies, Sensors & Transmitters, and On-Premise Deployment.
Leading companies in this market include Sartorius, Lonza, Revvity, Bio-Rad Laboratories, Tecan, Hamilton Company, Eppendorf, Mettler-Toledo, Repligen, Bio-Techne, GEA Group, and Spirax-Sarco Engineering.
The report provides a comprehensive analysis of the Biomanufacturing Automation Market, covering market size, growth drivers, restraints, and opportunities. It details market segmentation by various categories and profiles key companies, offering insights into the competitive landscape and regional dynamics.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
AI Biomanufacturing Intelligence Market
$684.0 Mn in 2025 · 25.1% CAGR
AI Laboratory Automation Market
$2.5 Bn in 2025 · 16.9% CAGR
Biofactory Automation Market
$3.4 Bn in 2025 · 14.8% CAGR
Biomanufacturing Market
$34.6 Bn in 2025 · 10.6% CAGR
Biomanufacturing Process Control Market
$3.9 Bn in 2025 · 11.8% CAGR
Biomanufacturing Scheduling Software Market
$386.0 Mn in 2025 · 12.0% CAGR
Clinical Trial Automation Market
$2.1 Bn in 2025 · 12.5% CAGR
Digital Bioprocess Automation Market
$1.7 Bn in 2025 · 15.7% CAGR